Results 121 to 130 of about 1,468 (156)
Some of the next articles are maybe not open access.
Southern Medical Journal, 1992
The imaging methods currently used to localize the parathyroid gland in patients with hyperparathyroidism have been criticized as unreliable and even misleading. We evaluated a new imaging technique that uses technetium Tc 99m sestamibi and iodine 123. We studied 21 patients having a diagnosis of primary hyperparathyroidism and no previous parathyroid ...
D J, Halvorson +3 more
openaire +2 more sources
The imaging methods currently used to localize the parathyroid gland in patients with hyperparathyroidism have been criticized as unreliable and even misleading. We evaluated a new imaging technique that uses technetium Tc 99m sestamibi and iodine 123. We studied 21 patients having a diagnosis of primary hyperparathyroidism and no previous parathyroid ...
D J, Halvorson +3 more
openaire +2 more sources
Journal of Ultrasound in Medicine, 2009
The purpose of this study was to determine the utility of radiologist-performed sonography as the principal modality for parathyroid localization before minimally invasive parathyroidectomy.Both sonography and technetium Tc 99m sestamibi single-photon emission computed tomography (SPECT) are commonly performed during imaging evaluation of patients with
Mitchell E, Tublin +6 more
openaire +2 more sources
The purpose of this study was to determine the utility of radiologist-performed sonography as the principal modality for parathyroid localization before minimally invasive parathyroidectomy.Both sonography and technetium Tc 99m sestamibi single-photon emission computed tomography (SPECT) are commonly performed during imaging evaluation of patients with
Mitchell E, Tublin +6 more
openaire +2 more sources
Technetium Tc 99m sestamibi myocardial perfusion imaging: current role for evaluation of prognosis.
Chest, 1999Like 201Tl imaging, technetium Tc 99m sestamibi (MIBI) myocardial imaging can be used with exercise and pharmacologic testing to assess the presence of coronary artery disease. An increasing body of literature indicates that MIBI can also be used to assess risk of future cardiac events such as myocardial infarction or death. This article summarizes the
B P, Mandalapu, M, Amato, H G, Stratmann
openaire +1 more source
American Journal of Kidney Diseases, 2005
The usefulness of both dual-phase dual-isotope iodine 123 ( 123 I)/technetium Tc 99m ( 99m Tc) sestamibi scintigraphy and ultrasonography for the detection of hyperplastic parathyroid glands secondary to renal hyperparathyroidism is rarely addressed; most studies focus on primary hyperparathyroidism.
Sophie, Périé +6 more
openaire +2 more sources
The usefulness of both dual-phase dual-isotope iodine 123 ( 123 I)/technetium Tc 99m ( 99m Tc) sestamibi scintigraphy and ultrasonography for the detection of hyperplastic parathyroid glands secondary to renal hyperparathyroidism is rarely addressed; most studies focus on primary hyperparathyroidism.
Sophie, Périé +6 more
openaire +2 more sources
European Journal of Nuclear Medicine and Molecular Imaging, 1998
Technetium-99m sestamibi (MIBI) is thought to be passively taken up by metabolically active tumour cells and effluxed from them by P-glycoprotein (Pgp). This 170-kDa membrane-bound protein, encoded by the MDR-1 gene, acts as an energy-dependent efflux pump for several antineoplastic agents, resulting in multidrug resistance.
K, Yokogami +10 more
openaire +2 more sources
Technetium-99m sestamibi (MIBI) is thought to be passively taken up by metabolically active tumour cells and effluxed from them by P-glycoprotein (Pgp). This 170-kDa membrane-bound protein, encoded by the MDR-1 gene, acts as an energy-dependent efflux pump for several antineoplastic agents, resulting in multidrug resistance.
K, Yokogami +10 more
openaire +2 more sources
Technetium Tc 99m Sestamibi Myocardial Perfusion Imaging
Chest, 1999Bhuvana P. Mandalapu +2 more
openaire +1 more source
TECHNETIUM [(99m)Tc] SESTAMIBI < Prop INN; BAN >
Drugs of the Future, 1989S.A. Carrell +3 more
openaire +1 more source
Clinical pharmacology and therapeutics, 2005
The adenosine triphosphate-binding cassette transporter ABCB1 (P-glycoprotein) mediates terminal excretion of many chemotherapeutic agents, and variable ABCB1 activity may be an important contributor to interpatient variability in the clearance of chemotherapeutic agents.
Mark, Wong +8 more
openaire +1 more source
The adenosine triphosphate-binding cassette transporter ABCB1 (P-glycoprotein) mediates terminal excretion of many chemotherapeutic agents, and variable ABCB1 activity may be an important contributor to interpatient variability in the clearance of chemotherapeutic agents.
Mark, Wong +8 more
openaire +1 more source